MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ARDS Aridis Pharmaceuticals
- 0.000
- +0.000+9900.00%
15min DelayClose Dec 20 16:00 ET
4.46KMarket Cap0.00P/E (TTM)
0.000High0.000Low27.17KVolume0.000Open0.000Pre Close2.72Turnover0.07%Turnover Ratio0.00P/E (Static)44.57MShares0.09352wk High0.00P/B3.80KFloat Cap0.00052wk Low--Dividend TTM37.96MShs Float13.850Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
Aridis Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 6,628.42%19.65M | 0 | 0 | 0 | 0 | 784.85%292K | 0 | 0 | 0 |
| Operating revenue | --0 | 6,628.42%19.65M | --0 | --0 | --0 | --0 | 784.85%292K | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -88.28%869K | -25.54%5.98M | -15.64%6.26M | -29.78%29.99M | -13.24%7.42M | -64.75%7.41M | 28.12%8.03M | 7.61%7.42M | 90.67%42.71M | 46.87%8.55M |
| Selling and administrative expenses | -34.38%1.11M | -22.07%1.31M | -16.06%1.81M | -2.04%7.16M | -17.59%1.63M | -0.35%1.69M | -0.77%1.68M | 11.16%2.16M | 13.42%7.31M | 23.93%1.97M |
| -General and administrative expense | -34.38%1.11M | -22.07%1.31M | -16.06%1.81M | -2.04%7.16M | -17.59%1.63M | -0.35%1.69M | -0.77%1.68M | 11.16%2.16M | 13.42%7.31M | 23.93%1.97M |
| Research and development costs | -97.14%175K | -26.47%4.67M | -14.25%5.53M | -29.82%25.92M | -7.39%7.01M | -69.17%6.12M | 38.81%6.35M | 30.17%6.45M | 117.83%36.94M | 78.82%7.57M |
| Other operating expenses | -4.51%-417K | ---- | 8.85%-1.08M | -101.37%-3.09M | -22.90%-1.21M | 22.52%-399K | ---- | ---1.19M | -53.50%-1.54M | ---987K |
| Operating profit | 88.28%-869K | 276.67%13.67M | 15.64%-6.26M | 29.78%-29.99M | 13.24%-7.42M | 64.75%-7.41M | -24.11%-7.74M | -7.61%-7.42M | -90.67%-42.71M | -46.87%-8.55M |
| Net non-operating interest income expense | 103.70%1K | -62.50%3K | 110.89%27K | 50.61%-121K | 159.11%146K | -2,800.00%-27K | 8K | -24,900.00%-248K | -418.18%-245K | -247K |
| Total other finance cost | -103.70%-1K | 62.50%-3K | -110.89%-27K | -50.61%121K | -159.11%-146K | 2,800.00%27K | ---8K | 24,900.00%248K | 418.18%245K | --247K |
| Other net income (expense) | 198.13%785K | -511.20%-1.53M | -517.02%-580K | -133.68%-257K | 8,163.64%887K | -3,578.26%-800K | -133.60%-250K | -1,442.86%-94K | 8,577.78%763K | -11K |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --722K | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---722K | --0 |
| Other non- operating income (expenses) | 198.13%785K | -511.20%-1.53M | -517.02%-580K | -726.83%-257K | 8,163.64%887K | -3,578.26%-800K | -1,236.36%-250K | -1,442.86%-94K | --41K | ---11K |
| Income before tax | 98.99%-83K | 252.20%12.14M | 12.23%-6.82M | 28.02%-30.37M | 27.50%-6.39M | 60.77%-8.24M | -45.34%-7.98M | -12.70%-7.77M | -88.93%-42.19M | -51.30%-8.81M |
| Income tax | ||||||||||
| Net income | 98.99%-83K | 252.20%12.14M | 12.23%-6.82M | 28.02%-30.37M | 27.50%-6.39M | 60.77%-8.24M | -45.34%-7.98M | -12.70%-7.77M | -88.93%-42.19M | -51.30%-8.81M |
| Net income continuous Operations | 98.99%-83K | 252.20%12.14M | 12.23%-6.82M | 28.02%-30.37M | 27.50%-6.39M | 60.77%-8.24M | -45.34%-7.98M | -12.70%-7.77M | -88.93%-42.19M | -51.30%-8.81M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 98.99%-83K | 252.20%12.14M | 12.23%-6.82M | 28.02%-30.37M | 27.50%-6.39M | 60.77%-8.24M | -45.34%-7.98M | -12.70%-7.77M | -88.93%-42.19M | -51.30%-8.81M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 4.13M | 0 | |||||||
| Net income attributable to common stockholders | 98.99%-83K | 252.20%12.14M | 12.23%-6.82M | 34.43%-30.37M | 27.50%-6.39M | 65.87%-8.24M | -45.34%-7.98M | 1.41%-7.77M | -107.41%-46.32M | -51.30%-8.81M |
| Basic earnings per share | 99.53%-0.0022 | 175.56%0.34 | 50.00%-0.22 | 57.03%-1.62 | 70.65%-0.27 | 75.77%-0.47 | 8.16%-0.45 | 42.86%-0.44 | -54.51%-3.77 | -55.93%-0.92 |
| Diluted earnings per share | 99.53%-0.0022 | 173.33%0.33 | 50.00%-0.22 | 57.03%-1.62 | 70.65%-0.27 | 75.77%-0.47 | 8.16%-0.45 | 42.86%-0.44 | -54.51%-3.77 | -55.93%-0.92 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
